Assessing coronary artery disease using CT angiography
Official title: Comprehensive Anatomical and Physiological Evaluation of Patients With Stable Coronary Artery Disease.
Run by CoreAalst BV · NCT06205810 · Data updated 2026-11-12
This study is testing how well a special heart scan called CT angiography can measure heart artery blockages in patients who need further heart tests.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | CoreAalst BV Industry-sponsored |
| Locations | 1 site (Aalst, Oost-Vlaanderen) |
| Status | Recruiting |
| Started | October 24, 2023 |
| Main results expected | October 15, 2030 |
| Study ends | October 15, 2031 |
| Registry record updated | January 20, 2026 |
| Trial ID | NCT06205810 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with epicardial stenosis greater than 50% who are indicated for invasive coronary angiography.
✕Probably not a fit
Patients with conditions such as STEMI, severe arrhythmias, or significant comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The COMPLETE study is an observational study focusing on patients who require invasive coronary angiography after undergoing coronary CT angiography (CCTA). It aims to evaluate the accuracy of CCTA in quantifying total atheroma volume, using intravascular ultrasound as a reference standard. Participants will be divided into two cohorts: those with stable coronary artery disease or stabilized acute coronary syndromes, and those previously revascularized with a metallic stent. Eligible patients must have significant epicardial stenosis identified through CCTA.
Why it matters
Potential benefit: If successful, this study could enhance the diagnostic accuracy for coronary artery disease, leading to better patient management and outcomes.
How similar studies have gone: Other studies have shown promising results in using CCTA for coronary artery disease assessment, indicating that this approach is supported by prior research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1\. Epicardial stenosis more than 50% by visual assessment. Exclusion Criteria: 1. STEMI. 2. Hemodynamic instability. 3. Rapid atrial fibrillation, flutter or arrhythmia (HR \> 80 bpm). 4. Insufficient CCTA image quality. 5. Age \<18 years. 6. Chronic obstructive pulmonary disease. 7. Contraindication to adenosine. 8. NYHA class III or IV, or last known left ventricular ejection fraction \<30%. 9. Uncontrolled or recurrent ventricular tachycardia. 10. History of recent stroke (≤90 days). 11. Prior myocardial infarction. 12. History of ischemic stroke (\>90 days) with modified RANKIN score ≥ 2. 13. History of any hemorrhagic stroke. 14. Previous coronary artery bypass surgery. 15. Active liver disease or hepatic dysfunction, defined as AST or ALT \> 3 times the ULN. 16. Severe renal dysfunction, defined as an eGFR \<30 mL/min/1.73 m2. 17. BMI \>35 kg/m2. 18. Nitrate intolerance 19. Contra-indication to heart rate lowering drugs. 20. Unable to provide written informed consent.
Where it's running
-
OLV Hospital Aalst
Aalst, Oost-Vlaanderen, Belgium Recruiting
Study contacts
- Principal investigator: Eric Wyffels, MD, PhD — OLV Hospital Aalst
- Study coordinator: Sofie Pardaens, MSc, PhD
- Email: sofiepardaens@coreaalst.com
- Phone: 0032 53 72 42 30
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.